Meeder Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
Other funds holding CCXI
RCM
EAM
Meeder Asset Management's CCXI Position: Q2 2021 in Review
Meeder Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q2 2021, closing a stake of 2,292 shares — an estimated $118K sold.
Meeder Asset Management first reported a position in CCXI in Q4 2016 and held it in 16 quarters. The position peaked at $228K in Q2 2020. 146 funds tracked by Wall St. Rank hold CCXI as of Q2 2021.
- Meeder Asset Management reported no remaining ChemoCentryx, Inc. position as of Q2 2021 after selling out during the quarter.
- Meeder Asset Management sold 2,292 ChemoCentryx, Inc. shares in Q2 2021, an estimated $118K.
- Meeder Asset Management first reported a position in ChemoCentryx, Inc. in Q4 2016 and held it in 16 quarters.
- Meeder Asset Management's ChemoCentryx, Inc. position peaked at $228K in Q2 2020.
- 146 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2021.
Based on Meeder Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.